يعرض 1 - 10 نتائج من 31 نتيجة بحث عن '"AR, allergic rhinitis"', وقت الاستعلام: 1.20s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3

    المصدر: Annals of Allergy, Asthma & Immunology

    مصطلحات موضوعية: Male, Allergy, Vital Capacity, DLCO, diffusing capacity for carbon monoxide, AR, Allergic rhinitis, Severity of Illness Index, Pulmonary function testing, 0302 clinical medicine, Risk Factors, Sars-CoV, Forced Expiratory Volume, Surveys and Questionnaires, Immunology and Allergy, Outpatient clinic, Prospective Studies, infections, 030212 general & internal medicine, Child, COVID, IL-13, interleukin-13, atopic dermatitis, medicine.diagnostic_test, Coinfection, Atopic dermatitis, CDC, The US Centers for Disease Control and Prevention, FEV1, forced expiratory volume in the first second, ICU, intensive care unit, CT, computed tomography, Hospitalization, Treatment Outcome, Child, Preschool, AD, Atopic dermatitis, PFT, pulmonary function testing, Female, Disease Susceptibility, Pulmonary and Respiratory Medicine, Spirometry, medicine.medical_specialty, Adolescent, pediatrics, ISAAC, International Study of Asthma and Allergies in Childhood, Immunology, sIgE, specific immunoglobulin E, FEF25–75, forced expiratory flow at 25%–75% of the vital capacity, Article, Dermatitis, Atopic, 03 medical and health sciences, rhinitis, ACE-2, Angiotensin-converting enzyme-2, Internal medicine, medicine, Humans, Risk factor, Asthma, SARS-CoV-2, business.industry, COVID-19, Infant, Odds ratio, asthma, medicine.disease, Rhinitis, Allergic, 030228 respiratory system, FVC, forced vital capacity, SPT, skin prick testing, PEF, peak expiratory flow, Tobacco Smoke Pollution, business

  4. 4
    دورية أكاديمية
  5. 5
  6. 6
  7. 7
  8. 8

    المصدر: The Lancet Regional Health-Europe
    Fritzsching, B, Contoli, M, Porsbjerg, C, Buchs, S, Larsen, J R, Elliott, L, Rodriguez, M R & Freemantle, N 2022, ' Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma : Results from the REACT study, a retrospective cohort study. ', The Lancet Regional Health-Europe, vol. 13, 100275 . https://doi.org/10.1016/j.lanepe.2021.100275Test
    The Lancet Regional Health. Europe, Vol 13, Iss, Pp 100275-(2022)

    مصطلحات موضوعية: Allergy, INCS, intranasal corticosteroids, Effectiveness, short-acting beta2-agonists (SABA), sublingual immunotherapy (SLIT), Allergic rhinitis, HDM, house dust mite, law.invention, AR, allergic rhinitis, intranasal corticosteroids (INCS), Randomized controlled trial, law, house dust mite (HDM), FU, follow-up, inhaled corticosteroids (ICS), SCIT, subcutaneous immunotherapy, retrospective cohort study, Real-world evidence, RCT, randomised clinical trial, biology, Health Policy, subcutaneous immunotherapy (SCIT), Oncology, HRU, health care resource utilisation, Cohort, Public aspects of medicine, RA1-1270, LABA, long-acting beta2-agonists, propensity score matching (PSM), real world evidence (RWE), Research Paper, Allergy immunotherapy (AIT), Retrospective cohort study, PSM, propensity score matching, medicine.medical_specialty, Allergen immunotherapy, allergic rhinitis (AR), Socio-culturale, effectiveness, health care resource utilisation (HRU), AIT, allergy immunotherapy, Rx prescription, Internal medicine, Internal Medicine, medicine, SABA, short-acting beta2-agonists, RWE, real world evidence, Asthma, House dust mite, business.industry, Rx, prescription, asthma, SLIT, sublingual immunotherapy, allergy, medicine.disease, biology.organism_classification, ICS, inhaled corticosteroids, randomised clinical trial (RCT), Allergy immunotherapy, follow-up (FU), Propensity score matching, Allergy immunotherapy (AIT), allergic rhinitis (AR), allergy, asthma, effectiveness, follow-up (FU), house dust mite (HDM), health care resource utilisation (HRU), inhaled corticosteroids (ICS), intranasal corticosteroids (INCS), long-acting beta2-agonists (LABA), propensity score matching (PSM), randomised clinical trial (RCT), real world evidence (RWE), retrospective cohort study, Rx prescription, short-acting beta2-agonists (SABA), subcutaneous immunotherapy (SCIT), sublingual immunotherapy (SLIT), long-acting beta2-agonists (LABA), business

    وصف الملف: application/pdf

  9. 9

    المصدر: World Allergy Organization Journal, Vol 14, Iss 1, Pp 100492-(2021)
    The World Allergy Organization Journal

  10. 10

    المساهمون: Federal University of Technology - Paraná (UTFPR), Universidade Federal do Pampa, University of Naples Federico II, Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI), Hospital Quirónsalud Bizkaia [Bilbao], University of Córdoba [Córdoba], Indoor Biotechnologies, Sanofi-Aventis R&D, SANOFI Recherche, University of Cartagena, Eye & Ear Hospital [Beirut], Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Nippon Medical School [Tokyo, Japon], University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), University of Naples Federico II = Università degli studi di Napoli Federico II, Università degli Studi di Firenze = University of Florence (UniFI), Universidad de Córdoba = University of Córdoba [Córdoba], Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Institut Desbrest de santé publique (IDESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Gestionnaire, HAL Sorbonne Université 5

    المصدر: World Allergy Organization Journal
    World Allergy Organization Journal, BMC, 2021, 14 (1), pp.100499. ⟨10.1016/j.waojou.2020.100499⟩
    World Allergy Organization Journal, 2021, 14 (1), pp.100499. ⟨10.1016/j.waojou.2020.100499⟩
    World Allergy Organization Journal, Vol 14, Iss 1, Pp 100499-(2021)
    The World Allergy Organization Journal

    مصطلحات موضوعية: Air pollution, Indoor air pollution, Environmental pollution, CO2, carbon dioxide, medicine.disease_cause, GST, glutathione S-transferase, AR, allergic rhinitis, 0302 clinical medicine, Indoor air quality, NCD, non-communicable disease, 11. Sustainability, Immunology and Allergy, [SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology, DEPs, diesel exhaust particles, 030223 otorhinolaryngology, media_common, VOCs, volatile organic compounds, Pollution, 6. Clean water, 3. Good health, CO, carbon monoxide, PMNs, polymorphonuclear leukocytes, BAL, bronchoalveolar lavage, [SDV.IMM.ALL] Life Sciences [q-bio]/Immunology/Allergology, NO2, nitrogen dioxide, Air pollutants, lcsh:Immunologic diseases. Allergy, Pulmonary and Respiratory Medicine, media_common.quotation_subject, Immunology, ILC2, innate lymphoid cells, O3, ozone, PM, particulate matter, Article, 03 medical and health sciences, HEPA, High Efficiency Particulate Arrestance, HEPA, Environmental health, medicine, FEV1, forced expiratory volume, TSLP, thymic stromal lymphopoietin, Air quality index, Pollutant, NO, nitric oxide, TRAP, Traffic-related air pollution, business.industry, Non-communicable disease, medicine.disease, HAP, household air pollution, PAH, polycyclic aromatic hydrocarbons, COPD, chronic obstructive pulmonary disease, 030228 respiratory system, FeNO, fractional exhaled nitric oxide, 13. Climate action, SO2, sulfur dioxide, lcsh:RC581-607, business, GM-CSF, granulocyte and macrophage growth stimulating factor

    وصف الملف: application/pdf